1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENERATION BIO CO
Generation Bio Co
XNAS: GBIO

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Generation Bio Co is on 07 May 2026 for the purpose of Generation Bio Co First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Generation Bio Co

The latest disclosure was made by Charles A. Rowland in Generation Bio Co where a trade of 5,200 Stock Option (right to buy) done was reported to US exchanges on Feb. 9, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Charles A. Rowland Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 5,200 0 - - Stock Option (right to buy)
Charles A. Rowland Director 09 Feb 2026 53,475 0 - - Common Stock
Charles A. Rowland Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Charles A. Rowland Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 4,246 0 - - Stock Option (right to buy)
Charles A. Rowland Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Charles A. Rowland Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Charles A. Rowland Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,920 0 - - Stock Option (right to buy)
Charles A. Rowland Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,500 0 - - Stock Option (right to buy)
Gustav A. Christensen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Gustav A. Christensen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Gustav A. Christensen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,920 0 - - Stock Option (right to buy)
Gustav A. Christensen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,500 0 - - Stock Option (right to buy)
Gustav A. Christensen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 5,200 0 - - Stock Option (right to buy)
Gustav A. Christensen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Gustav A. Christensen Director 09 Feb 2026 13,142 0 - - Common Stock
Jeffrey M. Jonas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,920 0 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,500 0 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 5,200 0 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 4,246 0 - - Stock Option (right to buy)
Anthony G. Quinn Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,500 0 - - Stock Option (right to buy)
Anthony G. Quinn Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 5,200 0 - - Stock Option (right to buy)
Anthony G. Quinn Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Anthony G. Quinn Director 09 Feb 2026 7,283 0 - - Common Stock
Anthony G. Quinn Director 09 Feb 2026 29,928 0 - - Common Stock
Anthony G. Quinn Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Anthony G. Quinn Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Anthony G. Quinn Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,920 0 - - Stock Option (right to buy)
Jason P. Rhodes Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 5,200 0 - - Stock Option (right to buy)
Jason P. Rhodes Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,500 0 - - Stock Option (right to buy)
Jason P. Rhodes Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,920 0 - - Stock Option (right to buy)
Jason P. Rhodes Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Jason P. Rhodes Director 09 Feb 2026 711,193 0 - - Common Stock
Jason P. Rhodes Director 09 Feb 2026 116,693 0 - - Common Stock
Jason P. Rhodes Director 09 Feb 2026 60 0 - - Common Stock
Jason P. Rhodes Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Jason P. Rhodes Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Geoffrey McDonough Director 09 Feb 2026 22,646 0 - - Common Stock
Geoffrey McDonough Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 19,903 0 - - Stock Option (right to buy)
Geoffrey McDonough Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 25,099 0 - - Stock Option (right to buy)
Geoffrey McDonough Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 37,499 0 - - Stock Option (right to buy)
Geoffrey McDonough Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 50,624 0 - - Stock Option (right to buy)
Geoffrey McDonough Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 24,046 0 - - Stock Option (right to buy)
Geoffrey McDonough Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 16,874 0 - - Stock Option (right to buy)
Geoffrey McDonough Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 90,168 0 - - Stock Option (right to buy)
Geoffrey McDonough Director 09 Feb 2026 138,492 0 - - Common Stock
Geoffrey McDonough Director 09 Feb 2026 27,500 0 - - Common Stock
Ronald Harold Wilfred Cooper Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Ronald Harold Wilfred Cooper Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Ronald Harold Wilfred Cooper Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,920 0 - - Stock Option (right to buy)
Ronald Harold Wilfred Cooper Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Ronald Harold Wilfred Cooper Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Ronald Harold Wilfred Cooper Director 09 Feb 2026 950 0 - - Common Stock
Catherine Stehman-Breen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,920 0 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,500 0 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 5,200 0 - - Stock Option (right to buy)
Catherine Stehman-Breen Director 09 Feb 2026 4,752 0 - - Common Stock
Donald W. Nicholson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Donald W. Nicholson Director 09 Feb 2026 21,357 0 - - Common Stock
Donald W. Nicholson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Donald W. Nicholson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 5,200 0 - - Stock Option (right to buy)
Donald W. Nicholson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Donald W. Nicholson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,500 0 - - Stock Option (right to buy)
Donald W. Nicholson Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,920 0 - - Stock Option (right to buy)
Yalonda Howze INTERIM CEO AND PRESIDENT Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 7,630 0 - - Stock Option (right to buy)
Yalonda Howze INTERIM CEO AND PRESIDENT 09 Feb 2026 3,759 0 - - Common Stock
Yalonda Howze INTERIM CEO AND PRESIDENT Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 10,710 0 - - Stock Option (right to buy)
Yalonda Howze INTERIM CEO AND PRESIDENT Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 11,883 0 - - Stock Option (right to buy)
Yalonda Howze INTERIM CEO AND PRESIDENT Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 25,102 0 - - Stock Option (right to buy)
Dannielle Appelhans Director 09 Feb 2026 1,263 0 - - Common Stock
Dannielle Appelhans Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 6,000 0 - - Stock Option (right to buy)
Dannielle Appelhans Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,500 0 - - Stock Option (right to buy)
Dannielle Appelhans Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,840 0 - - Stock Option (right to buy)
Dannielle Appelhans Director Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 3,000 0 - - Stock Option (right to buy)
Dannielle Appelhans Director 09 Feb 2026 736 0 - - Common Stock
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 5,940 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,800 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 2,585 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,399 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,763 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,061 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 283 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,192 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER 09 Feb 2026 2,072 0 - - Common Stock
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 621 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 550 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 1,877 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 35,525 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 249 0 - - Stock Option (right to buy)
Kevin Conway CHIEF FINANCIAL OFFICER Sale or transfer of securities back to the company at price $ 0.00 per share. 09 Feb 2026 200 0 - - Stock Option (right to buy)
Geoffrey McDonough Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. 02 Feb 2026 550 138,492 - 5.6 3,102 Common Stock
Geoffrey McDonough Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2026 1,582 139,042 - - Common Stock
Geoffrey McDonough Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2026 1,582 0 - - Restricted Stock Units
Yalonda Howze INTERIM CEO & PRESIDENT Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2026 1,673 0 - - Restricted Stock Units
Yalonda Howze INTERIM CEO & PRESIDENT Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. 02 Feb 2026 495 3,759 - 5.6 2,792 Common Stock
Yalonda Howze INTERIM CEO & PRESIDENT Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2026 1,673 4,254 - - Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2026 235 2,144 - - Common Stock
Kevin Conway Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. 02 Feb 2026 72 2,072 - 5.6 406 Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2026 235 0 - - Restricted Stock Units
Geoffrey McDonough Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2026 395 137,597 - - Common Stock
Geoffrey McDonough Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. 15 Jan 2026 137 137,460 - 5.6 773 Common Stock
Geoffrey McDonough Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2026 395 1,582 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2026 335 1,673 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2026 335 2,680 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. 15 Jan 2026 99 2,581 - 5.6 558 Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2026 59 1,926 - - Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2026 59 235 - - Restricted Stock Units
Kevin Conway Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.65 per share. 15 Jan 2026 17 1,909 - 5.6 96 Common Stock
Geoffrey McDonough Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2025 659 137,495 - - Common Stock
Geoffrey McDonough Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 31 Oct 2025 659 1,977 - - Restricted Stock Units
Geoffrey McDonough Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.51 per share. 31 Oct 2025 293 137,202 - 5.5 1,614 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 527 136,991 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 527 2,636 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.71 per share. 15 Oct 2025 155 136,836 - 6.7 1,040 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 334 2,444 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 334 2,008 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.71 per share. 15 Oct 2025 99 2,345 - 6.7 664 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 159 3,705 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 159 795 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.70 per share. 15 Oct 2025 47 3,658 - 6.7 315 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 114 573 - - Restricted Stock Units
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.71 per share. 15 Oct 2025 34 14,138 - 6.7 228 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 114 14,172 - - Common Stock
Kevin Conway Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.72 per share. 15 Oct 2025 18 1,867 - 6.7 121 Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 58 294 - - Restricted Stock Units
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 58 1,885 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 5,273 31,638 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 5,273 1,366,196 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 15 Jul 2025 1,548 1,364,648 - 0.4 659 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 15 Jul 2025 983 21,101 - 0.4 419 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 3,347 23,427 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 3,347 22,084 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 1,592 35,933 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 1,592 9,548 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 15 Jul 2025 468 35,465 - 0.4 199 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 1,147 6,876 - - Restricted Stock Units
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 15 Jul 2025 337 140,588 - 0.4 144 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 1,147 140,925 - - Common Stock
Kevin Conway Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 15 Jul 2025 173 18,273 - 0.4 74 Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 587 3,520 - - Restricted Stock Units
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2025 587 18,446 - - Common Stock
Charles A. Rowland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 30,000 - - Stock Option (right to buy)
Gustav A. Christensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 60,000 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 30,000 - - Stock Option (right to buy)
Anthony G. Quinn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 30,000 - - Stock Option (right to buy)
Jason P. Rhodes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 30,000 - - Stock Option (right to buy)
Ronald Harold Wilfred Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 30,000 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 30,000 - - Stock Option (right to buy)
Donald W. Nicholson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 30,000 - - Stock Option (right to buy)
Dannielle Appelhans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 30,000 30,000 - - Stock Option (right to buy)
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 5,274 36,911 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 5,274 1,351,212 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. 15 Apr 2025 1,548 1,349,664 - 0.4 569 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. 15 Apr 2025 983 18,737 - 0.4 362 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 3,347 26,774 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 3,347 19,720 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 1,592 11,140 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 1,592 23,550 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. 15 Apr 2025 468 23,082 - 0.4 172 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 1,147 128,856 - - Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. 15 Apr 2025 337 128,519 - 0.4 124 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 1,147 8,023 - - Restricted Stock Units
Kevin Conway Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. 15 Apr 2025 173 17,859 - 0.4 64 Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 587 4,107 - - Restricted Stock Units
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2025 587 18,032 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 5,274 42,185 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 5,274 1,347,766 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 1,828 1,345,938 - 0.9 1,623 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 1,160 16,373 - 0.9 1,030 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 3,347 17,533 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 3,347 30,121 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 1,592 22,510 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 1,592 12,732 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 552 21,958 - 0.9 490 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 1,147 9,170 - - Restricted Stock Units
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 398 127,709 - 0.9 353 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 1,147 128,107 - - Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 587 4,694 - - Restricted Stock Units
Kevin Conway Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 204 17,445 - 0.9 181 Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 587 17,649 - - Common Stock
Anthony G. Quinn Director Purchase of securities on an exchange or from another person at price $ 0.96 per share. 10 Jan 2025 125,791 214,286 - 1.0 120,759 Common Stock
Anthony G. Quinn Director Purchase of securities on an exchange or from another person at price $ 0.97 per share. 10 Jan 2025 85,000 299,286 - 1.0 82,450 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 901,690 901,690 - - Stock Option (right to buy)
Yalonda Howze CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 251,030 251,030 - - Stock Option (Right to Buy)
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 251,030 251,030 - - Stock Option (right to buy)
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 251,030 251,030 - - Stock Option (right to buy)
Kevin Conway Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 355,260 355,260 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,592 14,324 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 337 122,097 - 2.4 816 Common Stock
Paone Antionette CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,592 16,523 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 Oct 2024 983 14,186 - - Common Stock
Howze Yalonda CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 3,347 33,468 - - Restricted Stock Units
Stanton Matthew CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,674 15,059 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,673 1,673 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 5,274 47,459 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,674 15,059 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 492 57,348 - 2.4 1,191 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,673 57,840 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 5,274 1,339,177 - - Common Stock
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,674 56,659 - - Common Stock
Stanton Matthew CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,674 247,811 - - Common Stock
Stanton Matthew CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 492 247,319 - 2.4 1,191 Common Stock
Howze Yalonda CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. 15 Oct 2024 3,347 15,169 - 2.4 8,100 Common Stock
Paone Antionette CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 468 16,055 - 2.4 1,133 Common Stock
Samayoa Phillip CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,147 10,317 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 492 56,167 - 2.4 1,191 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 1,548 1,337,629 - 2.4 3,746 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,147 122,434 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 5,274 1,335,451 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 5,274 52,733 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 1,548 1,333,903 - 2.9 4,536 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,674 246,629 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 492 246,137 - 2.9 1,442 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,674 16,733 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 492 53,804 - 2.9 1,442 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,674 54,296 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,674 16,733 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 492 54,985 - 2.9 1,442 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,673 55,477 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,673 3,346 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 983 11,822 - 2.9 2,880 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 3,347 12,805 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 3,347 36,815 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,592 15,916 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,592 15,399 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 468 14,931 - 2.9 1,371 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 337 121,287 - 2.9 987 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,147 11,464 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,147 121,624 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 2.74 per share. 01 Jul 2024 6,719 13,807 - 2.7 18,410 Common Stock
Charles A. Rowland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Gustav A. Christensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Anthony G. Quinn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Jason P. Rhodes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Donald W. Nicholson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Dannielle Appelhans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 5,274 1,325,006 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 5,274 58,007 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 1,548 1,323,458 - 3.7 5,728 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,674 18,407 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,674 245,447 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 492 244,955 - 3.7 1,820 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,673 53,114 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 492 52,622 - 3.7 1,820 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,674 18,407 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,673 5,019 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,674 51,933 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 492 51,441 - 3.7 1,820 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 13,388 13,388 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 13,388 40,162 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 3,930 9,458 - 3.7 14,541 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,592 17,508 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,592 14,275 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 468 13,807 - 3.7 1,732 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,147 114,095 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 337 113,758 - 3.7 1,247 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,147 12,611 - - Restricted Stock Units
Kerr Douglas CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 5,021 0 - - Restricted Stock Units
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.90 per share. 29 Jan 2024 1,476 49,164 - 1.9 2,804 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.90 per share. 29 Jan 2024 1,476 385,628 - 1.9 2,804 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 5,021 387,104 - - Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 5,021 0 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 5,021 50,640 - - Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 21,094 63,281 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 246,093 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 1,674 50,840 - - Common Stock
Kerr Douglas CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 380,286 - - Common Stock
Kerr Douglas CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,320 382,083 - 1.9 4,431 Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,320 45,619 - 1.9 4,431 Common Stock
Paone Antionette CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 1,430 8,523 - 1.9 2,731 Common Stock
Kerr Douglas CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 7,437 - - Restricted Stock Units
Norkunas Matthew CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,320 49,166 - 1.9 4,431 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 21,094 1,327,042 - - Common Stock
Samayoa Phillip CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,125 111,381 - - Common Stock
Stanton Matthew CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,577 239,399 - 1.9 4,922 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 8,121 1,305,948 - 1.9 15,511 Common Stock
Samayoa Phillip CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 1,590 112,948 - 1.9 3,037 Common Stock
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 20,081 - - Restricted Stock Units
Kerr Douglas CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 20,081 - - Restricted Stock Units
Kerr Douglas CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,577 377,709 - 1.9 4,922 Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 47,939 - - Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 23,437 1,314,069 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,367 19,100 - - Restricted Stock Units
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 1,674 6,692 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 1,430 109,951 - 1.9 2,731 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,125 9,953 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,367 14,890 - - Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,577 41,245 - 1.9 4,922 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 0 - - Restricted Stock Units
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 51,486 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 241,976 - - Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 20,081 - - Restricted Stock Units
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 43,822 - - Common Stock
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 0 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 23,437 0 - - Restricted Stock Units
Samayoa Phillip CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,587 13,758 - - Restricted Stock Units
Stanton Matthew CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,320 243,773 - 1.9 4,431 Common Stock
Norkunas Matthew CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,577 44,792 - 1.9 4,922 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 47,369 - - Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 0 - - Restricted Stock Units
Stanton Matthew CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 20,081 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,207 12,683 - 1.9 4,215 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 7,310 1,319,732 - 1.9 13,962 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,587 114,538 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 581 50,259 - 1.9 1,110 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 384,403 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,125 0 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,125 0 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 160,650 160,650 - - Stock Option (right to buy)
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 160,650 160,650 - - Stock Option (right to buy)
Paone Antionette CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 1.62 per share. 02 Jan 2024 2,445 5,828 - 1.6 3,961 Common Stock
Samayoa Phillip CHIEF STRATEGY OFFICER Sale of securities on an exchange or to another person at price $ 1.62 per share. 02 Jan 2024 2,445 107,256 - 1.6 3,961 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 506,250 506,250 - - Stock Option (right to buy)
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 160,650 160,650 - - Stock Option (right to buy)
Howze Yalonda CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 118,837 118,837 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 160,650 160,650 - - Stock Option (right to buy)
Appelhans Dannielle Director Purchase of securities on an exchange or from another person at price $ 1.79 per share. 08 Dec 2023 7,363 7,363 - 1.8 13,180 Common Stock
Appelhans Dannielle Director Purchase of securities on an exchange or from another person at price $ 1.82 per share. 08 Dec 2023 637 12,637 - 1.8 1,159 Common Stock
Appelhans Dannielle Director Purchase of securities on an exchange or from another person at price $ 1.50 per share. 04 Dec 2023 12,000 12,000 - 1.5 18,000 Common Stock
G. Anthony Quinn Director Purchase of securities on an exchange or from another person at price $ 1.41 per share. 01 Dec 2023 88,495 88,495 - 1.4 124,778 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Howze Yalonda CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Norkunas Matthew CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Stanton Matthew CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Rowland Charles A. Director Purchase of securities on an exchange or from another person at price $ 1.31 per share. 01 Dec 2023 192,960 384,757 - 1.3 252,778 Common Stock
W. Donald Nicholson Director Purchase of securities on an exchange or from another person at price $ 1.44 per share. 01 Dec 2023 100,000 213,576 - 1.4 144,000 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 240,470 240,470 - - Stock Option (right to buy)
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 1.50 per share. 01 Dec 2023 150,000 534,757 - 1.5 225,000 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 4.93 per share. 23 Aug 2023 3,116 2,914 - 4.9 15,362 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 367,333 - - Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 14,874 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 2,183 365,150 - 5.1 11,090 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 23,437 46,874 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 23,437 1,282,621 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 7,476 1,275,145 - 5.1 37,978 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 14,874 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 231,468 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 2,183 229,285 - 5.1 11,090 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 2,183 31,131 - 5.1 11,090 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 3,348 10,040 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 14,874 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 983 33,496 - 5.1 4,994 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 3,348 34,479 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 33,314 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 2,183 31,131 - 5.1 11,090 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 14,874 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 33,314 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 4,125 7,241 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 1,211 6,030 - 5.1 6,152 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 4,125 8,250 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 4,125 8,250 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 1,211 104,342 - 5.1 6,152 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 4,125 105,553 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Sale of securities on an exchange or to another person at price $ 5.29 per share. 03 Jul 2023 3,116 101,428 - 5.3 16,484 Common Stock
Charles A. Rowland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Gustav A. Christensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Anthony G. Quinn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Jason P. Rhodes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Donald W. Nicholson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Dannielle Appelhans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 4.61 per share. 25 Apr 2023 2,914 0 - 4.6 13,434 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 2,183 356,780 - 4.5 9,824 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 358,963 - - Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 22,311 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 6,879 1,256,068 - 4.5 30,956 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 23,437 1,262,947 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 23,437 70,311 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 2,183 224,031 - 4.5 9,824 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 226,214 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 22,311 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 28,060 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 22,311 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 2,183 25,877 - 4.5 9,824 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 22,311 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 28,060 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 2,183 25,877 - 4.5 9,824 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 4,125 12,375 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 4,125 4,125 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 1,211 2,914 - 4.5 5,450 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 4,125 102,639 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 4,125 12,375 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 1,211 101,428 - 4.5 5,450 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 107,100 107,100 - - Stock Option (Right to Buy)
Yalonda Howze CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 53,550 53,550 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 5.56 per share. 26 Jan 2023 2,695 0 - 5.6 14,984 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 53,550 53,550 - - Stock Option (right to buy)
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 26,775 26,775 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 84,375 84,375 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 168,750 168,750 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 53,550 53,550 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 26,775 26,775 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 13,388 13,388 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 26,775 26,775 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 53,550 53,550 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 26,775 26,775 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 53,550 53,550 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 50,935 50,935 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 25,467 25,467 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 36,691 36,691 - - Stock Option (right to buy)
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 18,345 18,345 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 29,748 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 354,104 - - Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 2,578 351,526 - 5.1 13,148 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 23,438 93,748 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 23,438 1,247,632 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 8,122 1,239,510 - 5.1 41,422 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 29,748 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 2,578 218,777 - 5.1 13,148 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 221,355 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 23,201 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 29,748 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 2,578 20,623 - 5.1 13,148 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 23,201 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 29,748 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 2,578 20,623 - 5.1 13,148 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 1,430 2,695 - 5.1 7,293 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 4,125 16,500 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 4,125 4,125 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 4,125 99,944 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 4,125 16,500 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 1,430 98,514 - 5.1 7,293 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 4.57 per share. 10 Jan 2023 1,865 0 - 4.6 8,523 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Sale of securities on an exchange or to another person at price $ 5.11 per share. 09 Jan 2023 1,865 95,819 - 5.1 9,530 Common Stock
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 5.12 per share. 05 Jan 2023 9,500 9,500 - 5.1 48,640 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 5.03 per share. 27 Oct 2022 2,914 0 - 5.0 14,657 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 2,184 344,801 - 5.6 12,252 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 37,186 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 346,985 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 23,438 117,186 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 23,438 1,232,724 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 10,395 1,222,329 - 5.6 58,316 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 37,186 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 216,101 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 2,184 213,917 - 5.6 12,252 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 37,186 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 17,947 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 2,184 15,763 - 5.6 12,252 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 2,184 15,763 - 5.6 12,252 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 17,947 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 37,186 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 4,125 4,125 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 4,125 20,625 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 1,211 2,914 - 5.6 6,794 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 1,211 95,819 - 5.6 6,794 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 4,125 20,625 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 4,125 97,030 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 5.24 per share. 29 Sep 2022 2,828 0 - 5.2 14,819 Common Stock
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.26 per share. 19 Sep 2022 15,750 191,797 - 5.3 82,845 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 110,000 110,000 - - Stock Option (right to buy)
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.41 per share. 15 Sep 2022 17,147 142,566 - 5.4 92,765 Common Stock
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.48 per share. 15 Sep 2022 33,481 176,047 - 5.5 183,476 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 5.32 per share. 15 Sep 2022 4,610 2,828 - 5.3 24,525 Common Stock
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.20 per share. 13 Sep 2022 18,784 119,819 - 5.2 97,752 Common Stock
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.30 per share. 13 Sep 2022 5,600 125,419 - 5.3 29,652 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 343,914 - - Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 4,367 339,547 - 7.2 31,355 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 44,624 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 14,150 1,209,286 - 7.2 101,597 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 46,876 1,223,436 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 46,876 140,624 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 213,030 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 44,624 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 4,367 208,663 - 7.2 31,355 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 14,876 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 44,624 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 4,367 10,509 - 7.2 31,355 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 44,624 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 14,876 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 4,367 10,509 - 7.2 31,355 Common Stock
Dannielle Appelhans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 38,400 38,400 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 8,250 9,860 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 2,422 7,438 - 7.2 17,390 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 8,250 24,750 - - Restricted Stock Units
Charles A. Rowland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Gustav A. Christensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Anthony G. Quinn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Jason P. Rhodes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Donald W. Nicholson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Donald W. Nicholson Director Purchase of securities on an exchange or from another person at price $ 4.71 per share. 09 Mar 2022 8,126 113,576 - 4.7 38,273 Common Stock
Donald W. Nicholson Director Purchase of securities on an exchange or from another person at price $ 4.79 per share. 09 Mar 2022 2,293 105,450 - 4.8 10,983 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 59,500 59,500 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 119,000 119,000 - - Stock Option (right to buy)
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 187,500 187,500 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 375,000 375,000 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 59,500 59,500 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters